IL6 and neoplasm: Interestingly, PTIS-related vulnerabilities in PTR tumor growth were found to extend to metastasis with post-mortem analysis at experiment endpoint showing enhanced inhibition of tumor skin/abdominal wall invasion in PTR tumor variants after IFNAR1KD and IL6 inhibition compared to P controls (Fig. 7E).